Skip to main content
Erschienen in: Neurotoxicity Research 4/2015

01.05.2015 | Original Article

Neurotoxin-Induced DNA Damage is Persistent in SH-SY5Y Cells and LC Neurons

verfasst von: Yan Wang, Phillip R. Musich, Kui Cui, Yue Zou, Meng-Yang Zhu

Erschienen in: Neurotoxicity Research | Ausgabe 4/2015

Einloggen, um Zugang zu erhalten

Abstract

Degeneration of the noradrenergic neurons has been reported in the brain of patients suffering from neurodegenerative diseases. However, their pathological characteristics during the neurodegenerative course and underlying mechanisms remain to be elucidated. In the present study, we used the neurotoxin camptothecin (CPT) to induce the DNA damage response in neuroblastoma SH-SY5Y cells, normal fibroblast cells, and primarily cultured locus coeruleus (LC) and raphe neurons to examine cellular responses and repair capabilities after neurotoxin exposure. To our knowledge, the present study is the first to show that noradrenergic SH-SY5Y cells are more sensitive to CPT-induced DNA damage and deficient in DNA repair, as compared to fibroblast cells. Furthermore, similar to SH-SY5Y cells, primarily cultured LC neurons are more sensitive to CPT-induced DNA damage and show a deficiency in repairing this damage. Moreover, while N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP4) exposure also results in DNA damage in cultured LC neurons, neither CPT nor DSP4 induce DNA damage in neuronal cultures from the raphe nuclei. Taken together, noradrenergic SH-SY5Y cells and LC neurons are sensitive to CPT-induced DNA damage and exhibit a repair deficiency, providing a mechanistic explanation for the pathological characteristics of LC degeneration when facing endogenous and environmental DNA-damaging insults in vivo.
Literatur
Zurück zum Zitat Adolfsson R, Gottfries CG, Roos BE, Winblad B (1979) Changes in the brain catecholamines in patients with dementia of Alzheimer type. Br J Psychiatry 135:216–223CrossRefPubMed Adolfsson R, Gottfries CG, Roos BE, Winblad B (1979) Changes in the brain catecholamines in patients with dementia of Alzheimer type. Br J Psychiatry 135:216–223CrossRefPubMed
Zurück zum Zitat Arima K, Akashi T (1990) Involvement of the locus coeruleus in Pick’s disease with or without Pick body formation. Acta Neuropathol 79:629–633CrossRefPubMed Arima K, Akashi T (1990) Involvement of the locus coeruleus in Pick’s disease with or without Pick body formation. Acta Neuropathol 79:629–633CrossRefPubMed
Zurück zum Zitat Bassing CH, Alt FW (2004) H2AX may function as an anchor to hold broken chromosomal DNA ends in close proximity. Cell Cycle 3:149–153CrossRefPubMed Bassing CH, Alt FW (2004) H2AX may function as an anchor to hold broken chromosomal DNA ends in close proximity. Cell Cycle 3:149–153CrossRefPubMed
Zurück zum Zitat Bondareff W, Mountjoy CQ, Roth M (1982) Loss of neurons of origin of the adrenergic projection to cerebral cortex (nucleus locus ceruleus) in senile dementia. Neurology 32:164–168CrossRefPubMed Bondareff W, Mountjoy CQ, Roth M (1982) Loss of neurons of origin of the adrenergic projection to cerebral cortex (nucleus locus ceruleus) in senile dementia. Neurology 32:164–168CrossRefPubMed
Zurück zum Zitat Bondareff W, Mountjoy CQ, Roth M, Rossor MN, Iversen LL, Reynolds GP, Hauser DL (1987) Neuronal degeneration in locus ceruleus and cortical correlates of Alzheimer disease. Alzheimer Dis Assoc Disord 1:256–262CrossRefPubMed Bondareff W, Mountjoy CQ, Roth M, Rossor MN, Iversen LL, Reynolds GP, Hauser DL (1987) Neuronal degeneration in locus ceruleus and cortical correlates of Alzheimer disease. Alzheimer Dis Assoc Disord 1:256–262CrossRefPubMed
Zurück zum Zitat Brasnjevic I, Hof PR, Steinbusch HW, Schmitz C (2008) Accumulation of nuclear DNA damage or neuron loss: molecular basis for a new approach to understanding selective neuronal vulnerability in neurodegenerative diseases. DNA Repair (Amst) 7:1087–1097CrossRef Brasnjevic I, Hof PR, Steinbusch HW, Schmitz C (2008) Accumulation of nuclear DNA damage or neuron loss: molecular basis for a new approach to understanding selective neuronal vulnerability in neurodegenerative diseases. DNA Repair (Amst) 7:1087–1097CrossRef
Zurück zum Zitat Cassano T, Gaetani S, Morgese MG et al (2009) Monoaminergic changes in locus coeruleus and dorsal raphe nucleus following noradrenaline depletion. Neurochem Res 34:1417–1426CrossRefPubMedCentralPubMed Cassano T, Gaetani S, Morgese MG et al (2009) Monoaminergic changes in locus coeruleus and dorsal raphe nucleus following noradrenaline depletion. Neurochem Res 34:1417–1426CrossRefPubMedCentralPubMed
Zurück zum Zitat Chan-Palay V (1991a) Alterations in the locus coeruleus in dementias of Alzheimer’s and Parkinson’s disease. Prog Brain Res 88:625–630CrossRefPubMed Chan-Palay V (1991a) Alterations in the locus coeruleus in dementias of Alzheimer’s and Parkinson’s disease. Prog Brain Res 88:625–630CrossRefPubMed
Zurück zum Zitat Chan-Palay V (1991b) Locus coeruleus and norepinephrine in Parkinson’s disease. Jpn J Psychiatry Neurol 45:519–521PubMed Chan-Palay V (1991b) Locus coeruleus and norepinephrine in Parkinson’s disease. Jpn J Psychiatry Neurol 45:519–521PubMed
Zurück zum Zitat Chatterjee S, Cheng MF, Trivedi D, Petzold SJ, Berger NA (1989) Camptothecin hypersensitivity in poly(adenosine diphosphate-ribose) polymerase-deficient cell lines. Cancer Commun 1:389–394PubMed Chatterjee S, Cheng MF, Trivedi D, Petzold SJ, Berger NA (1989) Camptothecin hypersensitivity in poly(adenosine diphosphate-ribose) polymerase-deficient cell lines. Cancer Commun 1:389–394PubMed
Zurück zum Zitat Chen QM, Liu J, Merrett JB (2000) Apoptosis or senescence-like growth arrest: influence of cell-cycle position, p53, p21 and bax in H2O2 response of normal human fibroblasts. Biochem J 347:543–551CrossRefPubMedCentralPubMed Chen QM, Liu J, Merrett JB (2000) Apoptosis or senescence-like growth arrest: influence of cell-cycle position, p53, p21 and bax in H2O2 response of normal human fibroblasts. Biochem J 347:543–551CrossRefPubMedCentralPubMed
Zurück zum Zitat Chrobak JJ, DeHaven DL, Walsh TJ (1985) Depletion of brain norepinephrine with DSP-4 does not alter acquisition or performance of a radial-arm maze task. Behav Neural Biol 44:144–150CrossRefPubMed Chrobak JJ, DeHaven DL, Walsh TJ (1985) Depletion of brain norepinephrine with DSP-4 does not alter acquisition or performance of a radial-arm maze task. Behav Neural Biol 44:144–150CrossRefPubMed
Zurück zum Zitat Dooley DJ, Heal DJ, Goodwin GM (1987) Repeated electroconvulsive shock prevents increased neocortical beta 1-adrenoceptor binding after DSP-4 treatment in rats. Eur J Pharmacol 134:333–337CrossRefPubMed Dooley DJ, Heal DJ, Goodwin GM (1987) Repeated electroconvulsive shock prevents increased neocortical beta 1-adrenoceptor binding after DSP-4 treatment in rats. Eur J Pharmacol 134:333–337CrossRefPubMed
Zurück zum Zitat Downs JA, Lowndes NF, Jackson SP (2000) A role for Saccharomyces cerevisiae histone H2A in DNA repair. Nature 408:1001–1004CrossRefPubMed Downs JA, Lowndes NF, Jackson SP (2000) A role for Saccharomyces cerevisiae histone H2A in DNA repair. Nature 408:1001–1004CrossRefPubMed
Zurück zum Zitat Dunnett SB, Bjorklund A (1992) Staging and dissection of rat embryos. In: Dunnett SB, Bjorklund A (ed) Neuroa Dunnett SB, Bjorklund A (1992) Staging and dissection of rat embryos. In: Dunnett SB, Bjorklund A (ed) Neuroa
Zurück zum Zitat Fischer JB, Waggaman LA, Ransom RW, Cho AK (1983) Xylamine, an irreversible inhibitor of norepinephrine uptake, is transported by this same uptake mechanism in cultured rat superior cervical ganglia. J Pharmacol Exp Ther 226:650–655PubMed Fischer JB, Waggaman LA, Ransom RW, Cho AK (1983) Xylamine, an irreversible inhibitor of norepinephrine uptake, is transported by this same uptake mechanism in cultured rat superior cervical ganglia. J Pharmacol Exp Ther 226:650–655PubMed
Zurück zum Zitat Ford JM (2005) Regulation of DNA damage recognition and nucleotide excision repair: another role for p53. Mutat Res 577:195–202CrossRefPubMed Ford JM (2005) Regulation of DNA damage recognition and nucleotide excision repair: another role for p53. Mutat Res 577:195–202CrossRefPubMed
Zurück zum Zitat Fornai F, Bassi L, Torracca MT, Alessandri MG, Scalori V, Corsini GU (1996) Region- and neurotransmitter-dependent species and strain differences in DSP-4-induced monoamine depletion in rodents. Neurodegeneration 5:241–249CrossRefPubMed Fornai F, Bassi L, Torracca MT, Alessandri MG, Scalori V, Corsini GU (1996) Region- and neurotransmitter-dependent species and strain differences in DSP-4-induced monoamine depletion in rodents. Neurodegeneration 5:241–249CrossRefPubMed
Zurück zum Zitat Forno LS (1996) Neuropathology of Parkinson’s disease. J Neuropathol Exp Neurol 55:259–272CrossRefPubMed Forno LS (1996) Neuropathology of Parkinson’s disease. J Neuropathol Exp Neurol 55:259–272CrossRefPubMed
Zurück zum Zitat Fritschy JM, Grzanna R (1991) Experimentally-induced neuron loss in the locus coeruleus of adult rats. Exp Neurol 111:123–127CrossRefPubMed Fritschy JM, Grzanna R (1991) Experimentally-induced neuron loss in the locus coeruleus of adult rats. Exp Neurol 111:123–127CrossRefPubMed
Zurück zum Zitat Fritschy JM, Geffard M, Grzanna R (1990) The response of noradrenergic axons to systemically administered DSP-4 in the rat: an immunohistochemical study using antibodies to noradrenaline and dopamine-beta-hydroxylase. J Chem Neuroanat 3:309–321PubMed Fritschy JM, Geffard M, Grzanna R (1990) The response of noradrenergic axons to systemically administered DSP-4 in the rat: an immunohistochemical study using antibodies to noradrenaline and dopamine-beta-hydroxylase. J Chem Neuroanat 3:309–321PubMed
Zurück zum Zitat German DC, Manaye KF, White CL 3rd, Woodward DJ, McIntire DD, Smith WK, Kalaria RN, Mann DM (1992) Disease-specific patterns of locus coeruleus cell loss. Ann Neurol 32:667–676CrossRefPubMed German DC, Manaye KF, White CL 3rd, Woodward DJ, McIntire DD, Smith WK, Kalaria RN, Mann DM (1992) Disease-specific patterns of locus coeruleus cell loss. Ann Neurol 32:667–676CrossRefPubMed
Zurück zum Zitat Grudzien A, Shaw P, Weintraub S, Bigio E, Mash DC, Mesulam MM (2007) Locus coeruleus neurofibrillary degeneration in aging, mild cognitive impairment and early Alzheimer’s disease. Neurobiol Aging 28:327–335CrossRefPubMed Grudzien A, Shaw P, Weintraub S, Bigio E, Mash DC, Mesulam MM (2007) Locus coeruleus neurofibrillary degeneration in aging, mild cognitive impairment and early Alzheimer’s disease. Neurobiol Aging 28:327–335CrossRefPubMed
Zurück zum Zitat Hallman H, Jonsson G (1984) Pharmacological modifications of the neurotoxic action of the noradrenaline neurotoxin DSP4 on central noradrenaline neurons. Eur J Pharmacol 103:269–278CrossRefPubMed Hallman H, Jonsson G (1984) Pharmacological modifications of the neurotoxic action of the noradrenaline neurotoxin DSP4 on central noradrenaline neurons. Eur J Pharmacol 103:269–278CrossRefPubMed
Zurück zum Zitat Heneka MT, Ramanathan M, Jacobs AH et al (2006) Locus ceruleus degeneration promotes Alzheimer pathogenesis in amyloid precursor protein 23 transgenic mice. J Neurosci 26:1343–1354CrossRefPubMed Heneka MT, Ramanathan M, Jacobs AH et al (2006) Locus ceruleus degeneration promotes Alzheimer pathogenesis in amyloid precursor protein 23 transgenic mice. J Neurosci 26:1343–1354CrossRefPubMed
Zurück zum Zitat Hickson ID, Davies SL, Davies SM, Robson CN (1990) DNA repair in radiation sensitive mutants of mammalian cells: possible involvement of DNA topoisomerases. Int J Radiat Biol 58:561–568CrossRefPubMed Hickson ID, Davies SL, Davies SM, Robson CN (1990) DNA repair in radiation sensitive mutants of mammalian cells: possible involvement of DNA topoisomerases. Int J Radiat Biol 58:561–568CrossRefPubMed
Zurück zum Zitat Howard BD, Cho AK, Zhang MB, Koide M, Lin S (1990) Covalent labeling of the cocaine-sensitive catecholamine transporter. J Neurosci Res 26:149–158CrossRefPubMed Howard BD, Cho AK, Zhang MB, Koide M, Lin S (1990) Covalent labeling of the cocaine-sensitive catecholamine transporter. J Neurosci Res 26:149–158CrossRefPubMed
Zurück zum Zitat Jackisch R, Gansser S, Cassel JC (2008) Noradrenergic denervation facilitates the release of acetylcholine and serotonin in the hippocampus: towards a mechanism underlying upregulations described in MCI patients? Exp Neurol 213:345–353CrossRefPubMed Jackisch R, Gansser S, Cassel JC (2008) Noradrenergic denervation facilitates the release of acetylcholine and serotonin in the hippocampus: towards a mechanism underlying upregulations described in MCI patients? Exp Neurol 213:345–353CrossRefPubMed
Zurück zum Zitat Jonsson G, Hallman H, Ponzio F, Ross S (1981) DSP4 (N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine)—a useful denervation tool for central and peripheral noradrenaline neurons. Eur J Pharmacol 72:173–188CrossRefPubMed Jonsson G, Hallman H, Ponzio F, Ross S (1981) DSP4 (N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine)—a useful denervation tool for central and peripheral noradrenaline neurons. Eur J Pharmacol 72:173–188CrossRefPubMed
Zurück zum Zitat Kalinin S, Gavrilyuk V, Polak PE, Vasser R, Zhao J, Heneka MT, Feinstein DL (2007) Noradrenaline deficiency in brain increases beta-amyloid plaque burden in an animal model of Alzheimer’s disease. Neurobiol Aging 28:1206–1214CrossRefPubMed Kalinin S, Gavrilyuk V, Polak PE, Vasser R, Zhao J, Heneka MT, Feinstein DL (2007) Noradrenaline deficiency in brain increases beta-amyloid plaque burden in an animal model of Alzheimer’s disease. Neurobiol Aging 28:1206–1214CrossRefPubMed
Zurück zum Zitat Kang J, Ferguson D, Song H, Bassing C, Eckersdorff M, Alt FW, Xu Y (2005) Functional interaction of H2AX, NBS1, and p53 in ATM-dependent DNA damage responses and tumor suppression. Mol Cell Biol 25:661–670CrossRefPubMedCentralPubMed Kang J, Ferguson D, Song H, Bassing C, Eckersdorff M, Alt FW, Xu Y (2005) Functional interaction of H2AX, NBS1, and p53 in ATM-dependent DNA damage responses and tumor suppression. Mol Cell Biol 25:661–670CrossRefPubMedCentralPubMed
Zurück zum Zitat Liu LF, Desai SD, Li TK, Mao Y, Sun M, Sim SP (2000) Mechanism of action of camptothecin. Ann N Y Acad Sci 922:1–10CrossRefPubMed Liu LF, Desai SD, Li TK, Mao Y, Sun M, Sim SP (2000) Mechanism of action of camptothecin. Ann N Y Acad Sci 922:1–10CrossRefPubMed
Zurück zum Zitat Liu G, Yu J, Ding J et al (2014) Aldehyde dehydrogenase 1 defines and protects a nigrostriatal dopaminergic neuron subpopulation. J Clin Invest 124:3032–3046CrossRefPubMedCentralPubMed Liu G, Yu J, Ding J et al (2014) Aldehyde dehydrogenase 1 defines and protects a nigrostriatal dopaminergic neuron subpopulation. J Clin Invest 124:3032–3046CrossRefPubMedCentralPubMed
Zurück zum Zitat Lyness SA, Zarow C, Chui HC (2003) Neuron loss in key cholinergic and aminergic nuclei in Alzheimer disease: a meta-analysis. Neurobiol Aging 24:1–23CrossRefPubMed Lyness SA, Zarow C, Chui HC (2003) Neuron loss in key cholinergic and aminergic nuclei in Alzheimer disease: a meta-analysis. Neurobiol Aging 24:1–23CrossRefPubMed
Zurück zum Zitat Malagelada C, Ryu EJ, Biswas SC, Jackson-Lewis V, Greene LA (2006) RTP801 is elevated in Parkinson brain substantia nigral neurons and mediates death in cellular models of Parkinson’s disease by a mechanism involving mammalian target of rapamycin inactivation. J Neurosci 26:9996–10005CrossRefPubMed Malagelada C, Ryu EJ, Biswas SC, Jackson-Lewis V, Greene LA (2006) RTP801 is elevated in Parkinson brain substantia nigral neurons and mediates death in cellular models of Parkinson’s disease by a mechanism involving mammalian target of rapamycin inactivation. J Neurosci 26:9996–10005CrossRefPubMed
Zurück zum Zitat Mann DM (1983) The locus coeruleus and its possible role in ageing and degenerative disease of the human central nervous system. Mech Ageing Dev 23:73–94CrossRefPubMed Mann DM (1983) The locus coeruleus and its possible role in ageing and degenerative disease of the human central nervous system. Mech Ageing Dev 23:73–94CrossRefPubMed
Zurück zum Zitat Mann DM, Yates PO (1983) Pathological basis for neurotransmitter changes in Parkinson’s disease. Neuropathol Appl Neurobiol 9:3–19CrossRefPubMed Mann DM, Yates PO (1983) Pathological basis for neurotransmitter changes in Parkinson’s disease. Neuropathol Appl Neurobiol 9:3–19CrossRefPubMed
Zurück zum Zitat Mann DM, Yates PO, Hawkes J (1983) The pathology of the human locus ceruleus. Clin Neuropathol 2:1–7PubMed Mann DM, Yates PO, Hawkes J (1983) The pathology of the human locus ceruleus. Clin Neuropathol 2:1–7PubMed
Zurück zum Zitat Marien MR, Colpaert FC, Rosenquist AC (2004) Noradrenergic mechanisms in neurodegenerative diseases: a theory. Brain Res Brain Res Rev 45:38–78CrossRefPubMed Marien MR, Colpaert FC, Rosenquist AC (2004) Noradrenergic mechanisms in neurodegenerative diseases: a theory. Brain Res Brain Res Rev 45:38–78CrossRefPubMed
Zurück zum Zitat Martin GE, Elgin RJ Jr (1988) Effects of cerebral depletion of norepinephrine on conditioned avoidance responding in Sprague-Dawley and Fischer rats. Pharmacol Biochem Behav 30:137–142CrossRefPubMed Martin GE, Elgin RJ Jr (1988) Effects of cerebral depletion of norepinephrine on conditioned avoidance responding in Sprague-Dawley and Fischer rats. Pharmacol Biochem Behav 30:137–142CrossRefPubMed
Zurück zum Zitat Masuko S, Nakajima Y, Nakajima S, Yamaguchi K (1986) Noradrenergic neurons from the locus ceruleus in dissociated cell culture: culture methods, morphology, and electrophysiology. J Neurosci 6:3229–3241PubMed Masuko S, Nakajima Y, Nakajima S, Yamaguchi K (1986) Noradrenergic neurons from the locus ceruleus in dissociated cell culture: culture methods, morphology, and electrophysiology. J Neurosci 6:3229–3241PubMed
Zurück zum Zitat May P, May E (1999) Twenty years of p53 research: structural and functional aspects of the p53 protein. Oncogene 18:7621–7636CrossRefPubMed May P, May E (1999) Twenty years of p53 research: structural and functional aspects of the p53 protein. Oncogene 18:7621–7636CrossRefPubMed
Zurück zum Zitat Migliore L, Coppede F (2002) Genetic and environmental factors in cancer and neurodegenerative diseases. Mutat Res 512:135–153CrossRefPubMed Migliore L, Coppede F (2002) Genetic and environmental factors in cancer and neurodegenerative diseases. Mutat Res 512:135–153CrossRefPubMed
Zurück zum Zitat Morris EJ, Geller HM (1996) Induction of neuronal apoptosis by camptothecin, an inhibitor of DNA topoisomerase-I: evidence for cell cycle-independent toxicity. J Cell Biol 134:757–770CrossRefPubMed Morris EJ, Geller HM (1996) Induction of neuronal apoptosis by camptothecin, an inhibitor of DNA topoisomerase-I: evidence for cell cycle-independent toxicity. J Cell Biol 134:757–770CrossRefPubMed
Zurück zum Zitat Nagy Z, Esiri MM, Smith AD (1997) Expression of cell division markers in the hippocampus in Alzheimer’s disease and other neurodegenerative conditions. Acta Neuropathol 93:294–300CrossRefPubMed Nagy Z, Esiri MM, Smith AD (1997) Expression of cell division markers in the hippocampus in Alzheimer’s disease and other neurodegenerative conditions. Acta Neuropathol 93:294–300CrossRefPubMed
Zurück zum Zitat Offer H, Wolkowicz R, Matas D, Blumenstein S, Livneh Z, Rotter V (1999) Direct involvement of p53 in the base excision repair pathway of the DNA repair machinery. FEBS Lett 450:197–204CrossRefPubMed Offer H, Wolkowicz R, Matas D, Blumenstein S, Livneh Z, Rotter V (1999) Direct involvement of p53 in the base excision repair pathway of the DNA repair machinery. FEBS Lett 450:197–204CrossRefPubMed
Zurück zum Zitat Okorokov AL (2003) p53 in a crosstalk between DNA repair and cell cycle checkpoints. Cell Cycle 2:233–235CrossRefPubMed Okorokov AL (2003) p53 in a crosstalk between DNA repair and cell cycle checkpoints. Cell Cycle 2:233–235CrossRefPubMed
Zurück zum Zitat Palmer AM, DeKosky ST (1993) Monoamine neurons in aging and Alzheimer’s disease. J Neural Transm Gen Sect 91:135–159CrossRefPubMed Palmer AM, DeKosky ST (1993) Monoamine neurons in aging and Alzheimer’s disease. J Neural Transm Gen Sect 91:135–159CrossRefPubMed
Zurück zum Zitat Presgraves SP, Ahmed T, Borwege S, Joyce JN (2004) Terminally differentiated SH-SY5Y cells provide a model system for studying neuroprotective effects of dopamine agonists. Neurotox Res 5:579–598CrossRefPubMed Presgraves SP, Ahmed T, Borwege S, Joyce JN (2004) Terminally differentiated SH-SY5Y cells provide a model system for studying neuroprotective effects of dopamine agonists. Neurotox Res 5:579–598CrossRefPubMed
Zurück zum Zitat Prieto M, Giralt MT (2001) Effects of N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP4) on alpha2-adrenoceptors which regulate the synthesis and release of noradrenaline in the rat brain. Pharmacol Toxicol 88:152–158CrossRefPubMed Prieto M, Giralt MT (2001) Effects of N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP4) on alpha2-adrenoceptors which regulate the synthesis and release of noradrenaline in the rat brain. Pharmacol Toxicol 88:152–158CrossRefPubMed
Zurück zum Zitat Ransom RW, Waggaman LA, Cho AK (1985) Interaction of xylamine with peripheral sympathetic neurons. Life Sci 37:1177–1182CrossRefPubMed Ransom RW, Waggaman LA, Cho AK (1985) Interaction of xylamine with peripheral sympathetic neurons. Life Sci 37:1177–1182CrossRefPubMed
Zurück zum Zitat Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM (1998) DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem 273:5858–5868CrossRefPubMed Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM (1998) DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem 273:5858–5868CrossRefPubMed
Zurück zum Zitat Ross SB (1976) Long-term effects of N-2-chlorethyl-N-ethyl-2-bromobenzylamine hydrochloride on noradrenergic neurones in the rat brain and heart. Br J Pharmacol 58:521–527CrossRefPubMedCentralPubMed Ross SB (1976) Long-term effects of N-2-chlorethyl-N-ethyl-2-bromobenzylamine hydrochloride on noradrenergic neurones in the rat brain and heart. Br J Pharmacol 58:521–527CrossRefPubMedCentralPubMed
Zurück zum Zitat Rutten BP, Korr H, Steinbusch HW, Schmitz C (2003) The aging brain: less neurons could be better. Mech Ageing Dev 124:349–355CrossRefPubMed Rutten BP, Korr H, Steinbusch HW, Schmitz C (2003) The aging brain: less neurons could be better. Mech Ageing Dev 124:349–355CrossRefPubMed
Zurück zum Zitat Rutten BP, Schmitz C, Gerlach OH, Oyen HM, de Mesquita EB, Steinbusch HW, Korr H (2007) The aging brain: accumulation of DNA damage or neuron loss? Neurobiol Aging 28:91–98CrossRefPubMed Rutten BP, Schmitz C, Gerlach OH, Oyen HM, de Mesquita EB, Steinbusch HW, Korr H (2007) The aging brain: accumulation of DNA damage or neuron loss? Neurobiol Aging 28:91–98CrossRefPubMed
Zurück zum Zitat Srinivasan J, Schmidt WJ (2004) Behavioral and neurochemical effects of noradrenergic depletions with N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine in 6-hydroxydopamine-induced rat model of Parkinson’s disease. Behav Brain Res 151:191–199CrossRefPubMed Srinivasan J, Schmidt WJ (2004) Behavioral and neurochemical effects of noradrenergic depletions with N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine in 6-hydroxydopamine-induced rat model of Parkinson’s disease. Behav Brain Res 151:191–199CrossRefPubMed
Zurück zum Zitat Thiriet C, Hayes JJ (2005) Chromatin in need of a fix: phosphorylation of H2AX connects chromatin to DNA repair. Mol Cell 18:617–622CrossRefPubMed Thiriet C, Hayes JJ (2005) Chromatin in need of a fix: phosphorylation of H2AX connects chromatin to DNA repair. Mol Cell 18:617–622CrossRefPubMed
Zurück zum Zitat Thomas B, von Coelln R, Mandir AS et al (2007) MPTP and DSP-4 susceptibility of substantia nigra and locus coeruleus catecholaminergic neurons in mice is independent of parkin activity. Neurobiol Dis 26:312–322CrossRefPubMedCentralPubMed Thomas B, von Coelln R, Mandir AS et al (2007) MPTP and DSP-4 susceptibility of substantia nigra and locus coeruleus catecholaminergic neurons in mice is independent of parkin activity. Neurobiol Dis 26:312–322CrossRefPubMedCentralPubMed
Zurück zum Zitat Uday Bhanu M, Kondapi AK (2010) Neurotoxic activity of a topoisomerase-I inhibitor, camptothecin, in cultured cerebellar granule neurons. Neurotoxicology 31:730–737CrossRefPubMed Uday Bhanu M, Kondapi AK (2010) Neurotoxic activity of a topoisomerase-I inhibitor, camptothecin, in cultured cerebellar granule neurons. Neurotoxicology 31:730–737CrossRefPubMed
Zurück zum Zitat Usher M, Cohen JD, Servan-Schreiber D, Rajkowski J, Aston-Jones G (1999) The role of locus coeruleus in the regulation of cognitive performance. Science 283:549–554CrossRefPubMed Usher M, Cohen JD, Servan-Schreiber D, Rajkowski J, Aston-Jones G (1999) The role of locus coeruleus in the regulation of cognitive performance. Science 283:549–554CrossRefPubMed
Zurück zum Zitat Wang Y, Musich PR, Serrano MA, Zou Y, Zhang J, Zhu MY (2014) Effects of DSP4 on the noradrenergic phenotypes and its potential molecular mechanisms in SH-SY5Y Cells. Neurotox Res 25:193–207CrossRefPubMed Wang Y, Musich PR, Serrano MA, Zou Y, Zhang J, Zhu MY (2014) Effects of DSP4 on the noradrenergic phenotypes and its potential molecular mechanisms in SH-SY5Y Cells. Neurotox Res 25:193–207CrossRefPubMed
Zurück zum Zitat Weinshenker D (2008) Functional consequences of locus coeruleus degeneration in Alzheimer’s disease. Curr Alzheimer Res 5:342–345CrossRefPubMed Weinshenker D (2008) Functional consequences of locus coeruleus degeneration in Alzheimer’s disease. Curr Alzheimer Res 5:342–345CrossRefPubMed
Zurück zum Zitat Winkler H (1976) The composition of adrenal chromaffin granules: an assessment of controversial results. Neuroscience 1:65–80CrossRefPubMed Winkler H (1976) The composition of adrenal chromaffin granules: an assessment of controversial results. Neuroscience 1:65–80CrossRefPubMed
Zurück zum Zitat Zarow C, Lyness SA, Mortimer JA, Chui HC (2003) Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases. Arch Neurol 60:337–341CrossRefPubMed Zarow C, Lyness SA, Mortimer JA, Chui HC (2003) Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases. Arch Neurol 60:337–341CrossRefPubMed
Metadaten
Titel
Neurotoxin-Induced DNA Damage is Persistent in SH-SY5Y Cells and LC Neurons
verfasst von
Yan Wang
Phillip R. Musich
Kui Cui
Yue Zou
Meng-Yang Zhu
Publikationsdatum
01.05.2015
Verlag
Springer US
Erschienen in
Neurotoxicity Research / Ausgabe 4/2015
Print ISSN: 1029-8428
Elektronische ISSN: 1476-3524
DOI
https://doi.org/10.1007/s12640-015-9521-4

Weitere Artikel der Ausgabe 4/2015

Neurotoxicity Research 4/2015 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.